Gary Hattersley, Chief Scientific Officer at Radius Health, Inc. (RDUS), sold 11,302 shares at $65.00 ($735K) on 2015-10-23, disclosed to the SEC on 2015-10-27.
Scheduled sale ($735k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NUVB | SELL | 2025-10-29 | $1.0M | — | Filing → |
| RDUS | SELL | 2015-11-13 | $426K | — | Filing → |
| RDUS | SELL | 2015-11-05 | $933K | — | Filing → |